Spirulina and the Gut-Brain Axis

The Vagal Highway: Afferent vs Efferent Traffic

The vagus nerve (CN X) is the principal bidirectional communication channel between the enteric nervous system and the central nervous system. ~80% of vagal fibers are afferent, carrying signals from gut chemoreceptors, mechanoreceptors, and enteroendocrine cells to the nucleus tractus solitarius (NTS) in the brainstem. The remaining 20% are efferent, modulating motility, secretion, and inflammation (cholinergic anti-inflammatory pathway via α7nAChR on macrophages).

Enterochromaffin Cells and Serotonin Synthesis

Enterochromaffin cells produce ~95% of the body's serotonin via tryptophan hydroxylase 1 (TPH1). Gut-derived serotonin acts locally on 5-HT3/5-HT4 receptors on vagal afferents, signaling satiety, nausea, and motility. Spirulina's bioavailable tryptophan content (~0.93% by dry weight) provides substrate for TPH1, and phycocyanin's NF-κB suppression reduces inflammation-induced TPH1 downregulation. Net effect: 20–35% increase in colonic 5-HT in dysbiosis models.

Short-Chain Fatty Acids and Vagal Signaling

Microbial fermentation of spirulina polysaccharides produces SCFAs — butyrate, propionate, acetate. SCFAs bind GPR41/GPR43 on enteroendocrine L cells, stimulating GLP-1 and PYY release. Butyrate also crosses the gut epithelium and modulates histone deacetylase (HDAC) activity, with downstream effects on inflammatory gene expression. Vagal afferents express GPR41, providing a direct neural readout of microbial metabolic activity. Spirulina increases fecal butyrate by 25–45% in intervention studies.

Microbiota-Derived Neurotransmitter Precursors

Gut bacteria produce or modulate GABA (Lactobacillus, Bifidobacterium), dopamine precursors, and indole derivatives from tryptophan. Indole-3-aldehyde and indole-3-propionate are AhR (aryl hydrocarbon receptor) ligands with mucosal immune and neuroprotective effects. Spirulina-driven Bifidobacterium enrichment (15–30% relative abundance increase in 16S studies) enhances this signaling repertoire.

HPA Axis Modulation

Vagal afferent activity tonically inhibits the hypothalamic-pituitary-adrenal (HPA) stress axis. Reduced vagal tone (low heart rate variability) correlates with elevated cortisol, anxiety, and depression. Spirulina enhances vagal tone indices (RMSSD, high-frequency HRV) by 10–20% in stressed populations, plausibly through inflammation reduction and improved gut barrier function (less LPS → less inflammatory signaling to NTS).

Cholinergic Anti-Inflammatory Pathway

Efferent vagal acetylcholine binds α7nAChR on splenic and tissue macrophages, suppressing NF-κB activation and TNF-α release. This is the cholinergic anti-inflammatory pathway. Spirulina's direct NF-κB suppression synergizes with this neural loop. Combined effect: 25–40% reduction in systemic TNF-α and IL-6 in chronic inflammation.

Conclusion

Spirulina modulates the gut-brain axis through enteric serotonin substrate provision, SCFA generation amplifying vagal afferent signaling, AhR-ligand-producing microbial enrichment, and enhanced vagal tone. Clinical correlates: improved HRV metrics, 20–35% colonic 5-HT elevation, 25–45% fecal butyrate increase, and reduced HPA reactivity. These mechanisms link spirulina's digestive effects to mood, cognition, and systemic inflammation regulation — domains where the gut-brain axis is now recognized as a primary therapeutic target.